Apalutamide nanocrystalline formulation (Nanoform Finland Plc)
阿帕他胺纳米晶体制剂 (Nanoform Finland Plc)
Report date: 2025/05/19 16:12:56
Base Information
Drug NameApalutamide nanocrystalline formulation (Nanoform Finland Plc)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanoform Finland PLC
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A